Achieving precision, safety and compliance in biopharmaceutical manufacturing requires reliable, high-performance solutions. From fluid management and filtration to sealing and single-use technologies, innovative process control systems help enhance product integrity, accelerate drug development and meet stringent industry standards. With cutting edge solutions designed for scalability and efficiency, manufacturers can optimise bioprocessing workflows while ensuring the highest levels of purity and performance.
Find out more about Parker's biopharma processing capabilities below.
Parker utilises the latest technologies and extensive engineering and process expertise to advance bioprocessing with our PureTainĀ® single-use solutions.
The use of automation in running complex single use processes has many benefits including improving process control and consistency, increasing speed, and reducing human error deviations.
From clarification and bioburden reduction to sterile filtration and Mycoplasma removal, Parker offers a range of liquid and gas filters for all your filtration requirements. Filters can be incorporated into our SciLogĀ® single-use systems to enhance process control and increase productivity.
Parkerās single-use sensors for pressure, temperature and conductivity measurement enhance bioprocess control and safety making them fundamental for monitoring critical applications such as virus filtration, ultrafiltration and diafiltration and bulk drug dispense.
Interactive
Parker products and complete solutions for biopharmaceutical applications ensure high performance of the fluid control and filtration systems, maximising uptime and productivity. They are designed to meet the requirements of next generation Bioprocessing
Biopharmaceutical Industry Overview Guide
White Paper: Three ways to Successfully Scale-up
White Paper: Automation in Single-use
White Paper: Preventing Mycoplasma Contamination
White Paper: Demystifying Extractables Testing
White Paper: Implementation of Single-use
White Paper: Single-use-The next Five Challenges